7 completed, 1 unknown. 4 Not applicable, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 4 |
| Phase 3 | 2 | Completed 2 |
Follow Interactive Research and Development: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) Bedaquiline 100 MG, Delamanid 50 MG Oral Tablet, Clofazimine 100 MG Oral Capsule - Tuberculosis, Multidrug-Resistant, Tuberculosis | Phase 3 | Completed | Médecins Sans Frontières, France | 323 | 2020-04-06 | 2025-02-10 |
| Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis Multi-drug Resistant Tuberculosis | Unknown | University of Cape Town | 625 | 2020-01-30 | 2022-11-04 | |
| Evaluation of Conditional Cash Transfers (CCTs) for Immunization Conditional Cash Transfer, SMS Reminder - Immunization; Infection | Not applicable | Completed | Interactive Research and Development | 11197 | 2017-11-06 | 2020-07-29 |
| Immunization Reminder Bracelets Study Alma Sana Bracelet, Simple Silicon Bracelet - Immunization; Infection | Not applicable | Completed | Interactive Research and Development | 1445 | 2017-07-19 | 2019-02-19 |
| Evaluating Newly Approved Drugs for Multidrug-resistant TB Bedaquiline, Delamanid, Clofazimine - Tuberculosis, Multidrug-Resistant, Infection, Bacterial | Phase 3 | Completed | Médecins Sans Frontières, France | 754 | 2016-12-01 | 2025-02-10 |
| Expand New Drugs for TB [endTB] This is a non-intervention observational study - Tuberculosis, Multidrug-Resistant | Completed | Partners in Health | 2804 | 2015-04-01 | 2022-06-13 | |
| Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage SMS Reminder, Interactive Reminder - Immunization; Infection, SMS | Not applicable | Completed | Interactive Research and Development | 655 | 2011-05-23 | 2017-12-21 |
| Evaluating the Effectiveness of Interactive SMS Reminders on TB Treatment Outcomes Interactive Reminders - Tuberculosis | Not applicable | Completed | Interactive Research and Development | 2207 | 2011-03-01 | 2015-03-20 |
Tuberculosis, Multidrug-Resistant (4) · Infections (3) · Tuberculosis (3) · Bacterial Infections (2) · Tuberculosis, Pulmonary (2) · Extensively Drug-Resistant Tuberculosis (1) · Gram-Positive Bacterial Infections (1) · Mycobacterium Infections (1)
Clofazimine (2) · Linezolid (2) · OPC-67683 (2) · bedaquiline (2) · Levofloxacin (1) · Moxifloxacin (1) · Pyrazinamide (1) · Tablets (1)
Pakistan (7) · Kazakhstan (4) · Lesotho (4) · Peru (4) · South Africa (3) · Georgia (2) · India (2) · Vietnam (2) · Armenia (1) · Bangladesh (1) · Belarus (1) · Burma (1) · Ethiopia (1) · Indonesia (1) · Kenya (1)
Carole Mitnick, Sc.D (2) · Lorenzo Guglielmetti, MD (2) · Aamir J. Khan, MD/PhD. (1) · Aamir Khan (1) · Danya A Siddiqi, MSc (1) · Helen McIlleron, PhD (1) · Rachel Glennerster, PhD. (1) · Shama Mohammed, MPA/ID (1) · Subhash Chandir (1) · Subhash Chandir, Phd (1)
PMID 32813276, PMID 27802283, PMID 31666039, PMID 31676905, PMID 32652969, PMID 34563240, PMID 35028659, PMID 35784436, PMID 38037119, PMID 39879593, PMID 40683298, PMID 41626714